These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 27376050)

  • 21. Whooping Cough in Adults: A Series of Severe Cases.
    Zycinska K; Cieplak M; Chmielewska M; Nitsch-Osuch A; Klaczkow A; Hadzik-Blaszczyk M; Kur Z; Wardyn KA
    Adv Exp Med Biol; 2017; 955():47-50. PubMed ID: 28039663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel high-throughput assay to quantify the vaccine-induced inhibition of Bordetella pertussis adhesion to airway epithelia.
    Zanaboni E; Arato V; Pizza M; Seubert A; Leuzzi R
    BMC Microbiol; 2016 Sep; 16():215. PubMed ID: 27633511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against
    Jiang W; Wang X; Su Y; Cai L; Li J; Liang J; Gu Q; Sun M; Shi L
    Front Immunol; 2022; 13():878832. PubMed ID: 35493458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen.
    Mooi FR
    Infect Genet Evol; 2010 Jan; 10(1):36-49. PubMed ID: 19879977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species.
    Khelef N; Danve B; Quentin-Millet MJ; Guiso N
    Infect Immun; 1993 Feb; 61(2):486-90. PubMed ID: 8423077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases.
    Van den Steen P; Cheuvart B; Deraedt Q; Valdes Verelst L; Shamarina D
    Hum Vaccin Immunother; 2023 Dec; 19(1):2159731. PubMed ID: 36746754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines.
    Sukumar N; Sloan GP; Conover MS; Love CF; Mattoo S; Kock ND; Deora R
    Infect Immun; 2010 May; 78(5):2008-16. PubMed ID: 20176797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JMM Profile:
    Fry NK; Campbell H; Amirthalingam G
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34668853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pertussis vaccination and whooping cough: and now what?
    Guiso N
    Expert Rev Vaccines; 2014 Oct; 13(10):1163-5. PubMed ID: 25020131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An expert panel opinion on protection against pertussis in Mexico: The role of acellular and whole-cell vaccines.
    Colsa-Ranero A; Macías-Parra M; Hernández-Porras M; Xochihua-Díaz L; Galindo-Fraga A; Moreno-Espinosa S; Solórzano-Santos F
    Bol Med Hosp Infant Mex; 2022; 79(3):152-160. PubMed ID: 35882025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pertussis: New preventive strategies for an old disease.
    Di Mattia G; Nicolai A; Frassanito A; Petrarca L; Nenna R; Midulla F
    Paediatr Respir Rev; 2019 Feb; 29():68-73. PubMed ID: 29914744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity.
    Kerr JR; Matthews RC
    Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):77-88. PubMed ID: 10746492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults.
    Scott LJ
    BioDrugs; 2010 Dec; 24(6):387-406. PubMed ID: 21043546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spotlight on Tdap₅ vaccine (Covaxis®) as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis: in children (aged ≥4 years), adolescents, and adults.
    Scott LJ
    Paediatr Drugs; 2011 Apr; 13(2):133-5. PubMed ID: 21351814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pertussis vaccines: state-of-the-art and future trends.
    Tefon BE; Özcengiz E; Özcengiz G
    Curr Top Med Chem; 2013; 13(20):2581-96. PubMed ID: 24066885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.
    Taranger J; Trollfors B; Bergfors E; Knutsson N; Lagergård T; Schneerson R; Robbins JB
    Pediatrics; 2001 Dec; 108(6):E115. PubMed ID: 11731642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
    Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
    BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A controlled study of the relationship between Bordetella pertussis infections and sudden unexpected deaths among German infants.
    Heininger U; Kleemann WJ; Cherry JD;
    Pediatrics; 2004 Jul; 114(1):e9-15. PubMed ID: 15231967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination.
    Bart MJ; Harris SR; Advani A; Arakawa Y; Bottero D; Bouchez V; Cassiday PK; Chiang CS; Dalby T; Fry NK; Gaillard ME; van Gent M; Guiso N; Hallander HO; Harvill ET; He Q; van der Heide HG; Heuvelman K; Hozbor DF; Kamachi K; Karataev GI; Lan R; Lutyńska A; Maharjan RP; Mertsola J; Miyamura T; Octavia S; Preston A; Quail MA; Sintchenko V; Stefanelli P; Tondella ML; Tsang RS; Xu Y; Yao SM; Zhang S; Parkhill J; Mooi FR
    mBio; 2014 Apr; 5(2):e01074. PubMed ID: 24757216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duration of protection against Bordetella pertussis infection elicited by whole-cell and acellular vaccine priming in Polish children and adolescents.
    Paradowska-Stankiewicz I; Rumik A; Bogusz J; Zbrzeźniak J; Rastawicki W; Śmietańska K; Vargas-Zambrano JC; Macina D
    Vaccine; 2021 Oct; 39(41):6067-6073. PubMed ID: 34511302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.